 |  |  |  |  |  |
latest and greatest information on Extracorporeal Shockwave
Therapy (E.S.W.T.) and has created this website solely for this
purpose. We are the information center for E.S.W.T. helping our
viewers learn more about heel pain, also known as plantar fasciitis
(signs & causes), E.S.W.T. of course and the Orbasone.
The Orbasone is approved by the FDA to treat plantar fasciitis in the
heel using high-energy electrohydraulic (spark gap) shockwaves.
These shockwaves are focused to the treatment site allowing for
high efficiency and low re-treatment rate.
We welcome you to browse our website and contact us at our
corporate headquarters if you request further information.
02/23/2006 - Orthometrix, Inc. Forms Alliance with Healthcare Reimbursement Solutions,
Inc. to Provide Full Service to Podiatric and Orthopedic Practices Using its Orbasone
ESWT Pain Relief System to Treat Foot Pain.
09/20/2005 - Orthometrix, Inc. Announces First U.S. Sales of its
New Orbasone ESWT™ Pain Relief System to Treat Foot Pain
08/15/2005 - Orthometrix, Inc. Announces FDA Market Approval
For Its New Orbasone™ ESWT Pain Relief System To Treat
Foot Pain
Upcoming Exhibit Shows
June 15, 2006
Western Podiatric Medical Conference
Anaheim, CA
Booth #523A
April 27, 2006
Midwest Podiatry Conference
Chicago, IL
Booth #1311
April 26, 2006
American Association of Orthopaedic Medicine
Washington, DC
Booth #14
April 21, 2006
Washington State Podiatric Medical Association
Chelan, WA
Booth #TBA
April 21, 2006
Texas Podiatric Medical Association
Houston, TX
Booth #613
April 19, 2006
Mid-America Orthpaedic Association
San Antonio, TX
Booth #31
March 20, 2006
American College of Foot & Ankle Surgeons
Madalay Bay Hotel & Casino
Las Vegas, NV
Booth #108
January 20, 2006
NY State Podiatric Medical Association
Marriott Marquis
New York City, NY
Booth #216